Citeline Podcasts

On this week's podcast, Amanda Maxwell talks "Brexit" and the questions it raises for medtech regulations in Europe and the UK with David Filmore.

On this week's podcast, Amanda Maxwell talks "Brexit" and the questions it raises for medtech regulations in Europe and the UK with David Filmore.

On this week's podcast, we discuss the "Cancer Moonshot" Summit and the hopes medtech stakeholders have for the initiative; Roche's liquid biopsy plans; a guideline from FDA on handling potential advisory-panel member conflicts of interest and the latest on the "Open Payments" physician-payment database.

On this week's podcast, we discuss the "Cancer Moonshot" Summit and the hopes medtech stakeholders have for the initiative; Roche's liquid biopsy plans; a guideline from FDA on handling potential advisory-panel member conflicts of interest and the latest on the "Open Payments" physician-payment database.

On this week's podcast, we discuss the "Cancer Moonshot" Summit and the hopes medtech stakeholders have for the initiative; Roche's liquid biopsy plans; a guideline from FDA on handling potential advisory-panel member conflicts of interest and the latest on the "Open Payments" physician-payment database.

On this week's podcast, we discuss the Brexit vote, FDA guidance and user-fee negotiation updates, action on the Hill, a new director at the Office of Device Evaluation and a feature story on when device companies can (and can't) sue suppliers.

On this week's podcast, we discuss the Brexit vote, FDA guidance and user-fee negotiation updates, action on the Hill, a new director at the Office of Device Evaluation and a feature story on when device companies can (and can't) sue suppliers.

On this week's podcast, we discuss the Brexit vote, FDA guidance and user-fee negotiation updates, action on the Hill, a new director at the Office of Device Evaluation and a feature story on when device companies can (and can't) sue suppliers.

On this week's podcast, we discussed cybersecurity, colorectal cancer screening guidelines, tax and patent legal rulings, and a busy week from FDA with rules and guidance documents.

On this week's podcast, we discussed cybersecurity, colorectal cancer screening guidelines, tax and patent legal rulings, and a busy week from FDA with rules and guidance documents.